The Structural Heart Program at Terrebonne General Health System provides
minimally invasive procedures to treat life-threatening valve disorders
and structural heart defects. TGMC’s interventional cardiologist
and cardiovascular surgeons pioneer innovative heart solutions to bring
the best possible outcomes to our patients with structural heart diseases
and conditions.
Structural Heart & Valve Conditions
We treat patients with the following Structural Heart & Valve conditions:
Mitral valve stenosis
Aortic stenosis
Pulmonary valve stenosis and regurgitation
Patent foramen ovales
Aortic and mitral paravalvular leaks
Congenital heart defects such as patent ductus arteriosus, atrial septal
defect (ASD), and ventricular septal defect (VSD)
Congestive heart failure
Degenerative aortic bioprosthesis
Treatments & Services
Our innovative procedures include:
Transcatheter aortic valve replacement
Balloon valvuloplasty
Mitral valve repair with the MitraClip
Septal defect and patent foramen ovale closure
Left atrial appendage closure and ligation
Coronary fistula closure
Transcatheter paravalvular leak closure
Ongoing research trials for valvular and structural heart conditions
Hybrid Operating Room
Structural Heart procedures are performed in Terrebonne General’s
Hybrid Operating Room (OR). This advanced procedural space combines a
traditional operating room with an image guided interventional suite allowing
for highly complex, advanced surgical procedures. Not only are the rooms
combined but your care teams work together to form a multi-disciplinary
team prepared to meet the complex needs of our cardiology patients.
The ability to perform advanced imaging studies in the same surgery suite
eliminates the need to move patients during a procedure and reduces the
risk of infection. Patients also benefit by shorter procedure times, less
radiation used during imaging, reduced need for intensive care, shorter
hospital stays, and faster recovery. Terrebonne General’s Hybrid
OR suite also will be the surgical site for more groundbreaking clinical
trials, including percutaneous heart valve replacement, carotid artery
stenting, and lower extremity revascularization.
